GlassScriptPhysician profile
Matthew D Dunn
NPI 1639104326
$22,565.58
in general payments reported to CMS, 2019-2025
19 companies · $863 in 2025
The $863 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $187 · 2021: $11K · 2022: $479 · 2023: $7,846 · 2024: $1,432 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,825 · Food and Beverage: $2,761 · Travel and Lodging: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,825.00 |
| Food and Beverage | $2,760.65 |
| Travel and Lodging | $554.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $10,882.37 | 2020-2021 | |
| Karl Storz Endoscopy-America | $6,427.99 | 2019-2023 | Flex-X |
| Boston Scientific Corporation | $3,221.40 | 2019-2025 | General - Kidney Stone Disease, Moses, Lumenis Pulse 120h |
| C. R. Bard, INC. & Subsidiaries | $770.54 | 2022-2025 | Bard Urinary Drainage Bag, Bard Silicone Uretero-Intestinal Anastomosis Urinary Diversion Stent |
| Rochester Medical Corporation | $294.28 | 2021-2022 | |
| Cook Medical LLC | $170.86 | 2020-2025 | Litho 150 |
| Dornier Medtech America, INC | $163.67 | 2024 | Dornier Medtech |
| Olympus America INC. | $119.31 | 2019 | |
| Covidien LP | $94.23 | 2019 | |
| Becton, Dickinson and Company | $89.00 | 2023-2024 | Bard Urinary Drainage Bag |
| Gyrus Acmi, INC. | $80.00 | 2025 | Soltive |
| Intuitive Surgical, INC. | $54.17 | 2023 | Da Vinci Surgical System |
| Coloplast Corp | $47.75 | 2021 | |
| Halozyme INC | $47.24 | 2023 | |
| Abbvie INC. | $28.75 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $26.29 | 2024 | |
| Endo Pharmaceuticals INC. | $20.46 | 2022 | |
| Novo Nordisk INC | $13.99 | 2024 | |
| Progenics Pharmaceuticals, INC. | $13.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.